Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2010, Article ID 614395, 7 pages
http://dx.doi.org/10.4061/2010/614395
Research Article

Primitive Sca-1 Positive Bone Marrow HSC in Mouse Model of Aplastic Anemia: A Comparative Study through Flowcytometric Analysis and Scanning Electron Microscopy

Stem Cell Research and Application Unit, Department of Biochemistry and Medical Biotechnology, Calcutta School of Tropical Medicine, 108, C.R. Avenue, Kolkata-700073, India

Received 30 April 2009; Revised 30 June 2009; Accepted 4 August 2009

Academic Editor: Pranela Rameshwar

Copyright © 2010 Sumanta Chatterjee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kondo, A. J. Wagers, M. G. Manz et al., “Biology of hematopoietic stem cells and progenitors: implications for clinical application,” Annual Review of Immunology, vol. 21, pp. 759–806, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Yang, D. Bryder, J. Adolfsson et al., “Identification of Lin-Sca-1+Kit+CD34+Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients,” Blood, vol. 105, no. 7, pp. 2717–2723, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. D. N. Haylock, B. Williams, H. M. Johnston et al., “Hemopoietic stem cells with higher hemopoietic potential reside at the bone marrow endosteum,” Stem Cells, vol. 25, no. 4, pp. 1062–1069, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Christensen and I. L. Weissman, “Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 25, pp. 14541–14546, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. Spangrude, S. Heimfeld, and I. L. Weissman, “Purification and characterization of mouse hematopoietic stem cells,” Science, vol. 241, no. 4861, pp. 58–62, 1988. View at Google Scholar · View at Scopus
  6. S. Okada, H. Nakauchi, K. Nagayoshi, S.-I. Nishikawa, Y. Miura, and T. Suda, “In vivo and in vitro stem cell function of C-kit- and Sca-1-positive murine hematopoietic cells,” Blood, vol. 80, no. 12, pp. 3044–3050, 1992. View at Google Scholar · View at Scopus
  7. Y. Matsuzaki, K. Kinjo, R. C. Mulligan et al., “Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells,” Immunity, vol. 20, no. 1, pp. 87–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Takano, H. Ema, K. Sudo, and H. Nakauchi, “Asymmetric division and lineage commitment at the level of hematopoietic stem cells: inference from differentiation in daughter cell and granddaughter cell pairs,” The Journal of Experimental Medicine, vol. 199, no. 3, pp. 295–302, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Akashi, D. Traver, T. Miyamoto et al., “A clonogenic common myeloid progenitor that gives rise to all myeloid lineages,” Nature, vol. 404, no. 6774, pp. 193–197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Trevisan and N. N. Iscove, “Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony- forming progeny,” The Journal of Experimental Medicine, vol. 181, no. 1, pp. 93–103, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kondo, I. L. Weissman, and K. Akashi, “Identification of clonogenic common lymphoid progenitors in mouse bone marrow,” Cell, vol. 91, no. 5, pp. 661–672, 1997. View at Google Scholar · View at Scopus
  12. J. L. Curry, J. J. Trentin, and N. Wolf, “Hemopoietic spleen colony studies. II. Erythropoiesis,” The Journal of Experimental Medicine, vol. 125, no. 4, pp. 703–720, 1967. View at Google Scholar · View at Scopus
  13. R. Schofield, “The relationship between the spleen colony-forming cell and the haemopoietic stem cell,” Blood Cells, vol. 4, no. 1-2, pp. 7–25, 1978. View at Google Scholar · View at Scopus
  14. H.-G. Kopp, S. T. Avecilla, A. T. Hooper, and S. Rafii, “The bone marrow vascular niche: home of HSC differentiation and mobilization,” Physiology, vol. 20, no. 5, pp. 349–356, 2005. View at Google Scholar · View at Scopus
  15. S. Rafii, R. Mohle, F. Shapiro, B. M. Frey, and M. A. S. Moore, “Regulation of hematopoiesis by microvascular endothelium,” Leukemia and Lymphoma, vol. 27, no. 5-6, pp. 375–386, 1997. View at Google Scholar · View at Scopus
  16. J. Domen and I. L. Weissman, “Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate,” Molecular Medicine Today, vol. 5, no. 5, pp. 201–208, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Wilson and A. Trumpp, “Bone-marrow haematopoietic-stem-cell niches,” Nature Reviews Immunology, vol. 6, no. 2, pp. 93–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. N. S. Young, “Acquired Aplastic anemia,” Annals of Internal Medicine, vol. 136, no. 7, pp. 534–546, 2002. View at Google Scholar · View at Scopus
  19. N. S. Young, “Aplastic anemia, myelodysplasia, related bone marrow failure syndromes,” in Harrisons Principles of Internal Medicine, D. L. Kasper, E. Braunwald, A. S. Fauci, S. L. Hauser, D. L. Longo, and J. L. Jameson, Eds., pp. 617–626, McGraw-Hill, New York, NY, USA, 2005. View at Google Scholar
  20. P. Ehrlich, “Uber einen Fall Von Anime mit Bemerkungen uber regenerative veraenderungen des Knochenmarks,” Charite-Annalen, vol. 13, p. 300, 1888. View at Google Scholar
  21. J. P. Maciejewski, C. Selleri, T. Sato et al., “A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired Aplastic anemia,” Blood, vol. 88, no. 6, pp. 1983–1991, 1996. View at Google Scholar · View at Scopus
  22. J. Scopes, M. Bagnara, E. C. Gordon-Smith et al., “Haemopoietic progenitor cells are reduced in Aplastic anaemia,” British Journal of Haematology, vol. 86, no. 2, pp. 427–430, 1994. View at Google Scholar · View at Scopus
  23. K. Yoshida, I. Miura, T. Takahashi et al., “Quantitative and qualitative analysis of stem cells of patients with Aplastic anaemia,” Scandinavian Journal of Haematology, vol. 30, no. 4, pp. 317–323, 1983. View at Google Scholar · View at Scopus
  24. S. Law and S. Chaudhuri, “Niche theory, stem-stromal imbalance and Aplastic anaemia,” Journal of Stem Cells, vol. 2, no. 4, pp. 227–235, 2007. View at Google Scholar
  25. H. S. Juneja, S. Lee, and F. H. Gardner, “Human long-term bone marrow cultures in Aplastic anemia,” International Journal of Cell Cloning, vol. 7, no. 2, pp. 129–135, 1989. View at Google Scholar · View at Scopus
  26. N. Testa, J. Heardy, and G. Molineux, “Long term bone marrow damage after cytotoxic treatment: stem cells and microenvironment,” in Hematopoiesis, N. G. Testa and R. P. Gale, Eds., Marcel Dekker, New York, NY, USA, 1988. View at Google Scholar
  27. P. H. Krammer, “CD95's deadly mission in the immune system,” Nature, vol. 407, no. 6805, pp. 789–795, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. N. S. Young, “Hematopoietic cell destruction by immune mechanisms in acquired Aplastic anemia,” Seminars in Hematology, vol. 37, no. 1, pp. 3–14, 2000. View at Google Scholar · View at Scopus
  29. J. P. Maciejewski, C. Selleri, T. Sato, S. Anderson, and N. S. Young, “Increased expression of Fas antigen on bone marrow CD34+ cells of patients with Aplastic anaemia,” British Journal of Haematology, vol. 91, no. 1, pp. 245–252, 1995. View at Google Scholar · View at Scopus
  30. W. Li, J. Fu, F. Wang et al., “Distinct overexpression of Fas ligand on T lymphocytes in Aplastic anemia,” Cellular & Molecular Immunology, vol. 1, no. 2, pp. 142–147, 2004. View at Google Scholar
  31. J. Chen, “Animal models for acquired Bone marrow failure syndromes,” Clinical Medicine & Research, vol. 3, no. 2, pp. 102–108, 2005. View at Google Scholar
  32. A. Marley and J. Blake, “An animal model of chronic Aplastic marrow failure. I. Late marrow failure after busulfan,” Blood, vol. 44, no. 1, pp. 49–56, 1974. View at Google Scholar
  33. S. Law, D. Maiti, A. Palit et al., “Facilitation of functional compartmentalization of bone marrow cells in leukemic mice by biological response modifiers: an immunotherapeutic approach,” Immunology Letters, vol. 76, no. 3, pp. 145–152, 2001. View at Google Scholar
  34. S. Law, D. Maiti, A. Palit, and S. Chaudhuri, “Role of biomodulators and involvement of protein tyrosine kinase on stem cell migration in normal and leukaemic mice,” Immunology Letters, vol. 86, no. 3, pp. 287–290, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Hugo, Malaspina, and J. O. Richard, “Anemia and related disorders,” in Cecil Textbook of Medicine, L. Goldman and D. Ausiello, Eds., pp. 1242–1243, Elsevier, New York, NY, USA, 2007. View at Google Scholar
  36. K. J. Trainor and A. A. Morley, “Screening of cytotoxic drugs for residual bone marrow damage,” Journal of the National Cancer Institute, vol. 57, no. 6, pp. 1237–1240, 1976. View at Google Scholar · View at Scopus
  37. C. A. J. Pugsley, I. J. Forbes, and A. A. Morley, “Immunologic abnormalities in an animal model of chronic hypoplastic marrow failure induced by busulfan,” Blood, vol. 51, no. 4, pp. 601–610, 1978. View at Google Scholar · View at Scopus
  38. J. J. Twomey, C. C. Douglass, and O. Sharkey Jr., “The monocytopenia of Aplastic anemia,” Blood, vol. 41, no. 2, pp. 187–195, 1973. View at Google Scholar · View at Scopus
  39. A. Morley, K. Trainor, and J. Blake, “A primary stem cell lesion in experimental chronic hypoplastic marrow failure,” Blood, vol. 45, no. 5, pp. 681–688, 1975. View at Google Scholar · View at Scopus
  40. A. Morley and J. Blake, “Haemopoietic precursor cells in experimental hypoplastic marrow failure,” Australian Journal of Experimental Biology and Medical Science, vol. 52, no. 6, pp. 909–914, 1974. View at Google Scholar · View at Scopus
  41. L. E. Botnick, E. C. Hannon, and S. Hellman, “A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents,” International Journal of Radiation Oncology, Biology, Physics, vol. 5, no. 9, pp. 1621–1625, 1979. View at Google Scholar · View at Scopus
  42. J. H. Fitchen, J. Deregnaucourt, and M. J. Cline, “An in vitro model of hematopoietic injury in chronic hypoplastic anemia,” Cell and Tissue Kinetics, vol. 14, no. 1, pp. 85–90, 1981. View at Google Scholar · View at Scopus
  43. J. L. Millar, B. N. Hudspith, and N. M. Blackett, “Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan,” British Journal of Cancer, vol. 32, no. 2, pp. 193–198, 1975. View at Google Scholar · View at Scopus